CAHON Connect May 2026 Newsletter
Message from the President and Chair of Board
Dear CAHON Members, Colleagues, and Friends,
As we continue an exciting and productive year for CAHON, we would like to thank all of you for your continued engagement, support, and commitment to our community.
Over the past several months, CAHON has continued to expand its educational programs, mentorship initiatives, professional networking opportunities, and membership engagement across our growing community. From our highly successful Community Oncology Forum and Post-ASH Virtual Update to our Career Pathways and Fellowship Application webinars, we have seen strong participation across trainees, junior faculty, community oncologists, researchers, and industry colleagues. In particular, the newly launched CAHON Quarterly Seminar Series has become an important platform for mentorship, academic exchange, and professional development by bringing together senior faculty, junior faculty, and fellows in a collaborative learning environment. These activities reflect the strength, diversity, and growing impact of our network.
One of the most encouraging developments this year has been the extraordinary level of member engagement. We received a record number of volunteers for the 2026–2028 Executive Team, highlighting the enthusiasm and dedication within our community to help shape CAHON’s future. Our committees continue to drive impactful programming in academic development, clinical practice, clinical research, mentorship, wellness, education, and public outreach.
We are also proud to celebrate the accomplishments of our members, whose contributions continue to elevate the visibility and impact of Chinese American physicians and scientists in hematology, oncology, and cancer research. Whether through major national awards, leadership appointments, groundbreaking research publications, or clinical innovation, CAHON members are making meaningful contributions across academia, industry, and patient care.
At the same time, we remain deeply committed to fostering a supportive and collaborative professional community. The recent physician wellness survey conducted through the Community Oncology Forum highlighted both the challenges many oncologists face and the strong interest in greater peer connection, mentorship, wellness programming, and practical strategies to support physician well-being. In response to this feedback, CAHON plans to launch a dedicated Wellness Committee beginning with the new term in June 2026. We hope this initiative will help further promote professional sustainability, community support, and physician wellness across all career stages.
Looking ahead, we are excited for several upcoming events, including the Summer Symposium and Reception during ASCO, the New York Oncology Forum, the inaugural Fall Symposium during the SITC Annual Meeting, and our Winter Symposium and Reception. We hope these gatherings will continue to strengthen collaboration, mentorship, friendship, and community across CAHON.
Finally, we would like to express our sincere gratitude to our board members, executive committee members, volunteers, corporate partners, and all CAHON members for your dedication and generosity. CAHON’s continued growth and success are only possible because of your efforts and shared vision.
Together, we are building a stronger and more connected community dedicated to advancing hematology, oncology, research, mentorship, and patient care.
With gratitude and best wishes,
Liang Deng, MD, PhD
CAHON President
Jing-Zhou Hou, MD, PhD
CAHON Board Chair
Chinese American Hematologist and Oncologist Network (CAHON)
Featured News
CAHON Community Oncology Forum, February 2026, Physician Wellness Survey - Executive Summary | Jane Liu
Background:
Recent surveys report burnout rates approaching 59% among oncologists, up from 45% a decade earlier.
Findings:
A 7-question wellness survey of 40 CAHON physicians assessed burnout, work–life balance, and lifestyle habits. Results indicate that burnout is common: only 15% reported never feeling emotionally exhausted, while nearly 40% experience burnout weekly or more often. Clinical responsibilities also affect personal life for many respondents, with over 75% reporting some negative impact on family or personal time.
Lifestyle patterns suggest opportunities for improvement. Most respondents sleep 6–7 hours per night, slightly below optimal levels (7-9 hours) for adults per NCCN guideline and national sleep foundation (26-64 years old). While 60% report exercising at least three times per week, a significant portion report less frequent physical activity. Nutrition is also affected by work demands, with about three-quarters reporting occasional or frequent skipped meals or inadequate nutrition.
Use of formal stress-management strategies remains limited: half of respondents rarely or never use practices such as mindfulness, breathing exercises, or stretching.
Open-ended responses highlighted several areas where CAHON could support member well-being, including peer connection, networking opportunities, wellness and stress-management programs, physical activity initiatives, and community-building activities.
Overall, the findings suggest that CAHON physician stress and work–life challenges are common, while members express strong interest in wellness initiatives and practical strategies to support physician well-being.
Members Making an Impact
Vincent T. Ma, MD
Speaking Engagement at the 2026 National Comprehensive Cancer Network (NCCN) Annual Conference
Dr. Vincent Ma was honored to present at the prestigious National Comprehensive Cancer Network (NCCN) Annual Conference on March 27th. This year’s conference centered on the practical management of patients with cancer, updates on NCCN Guidelines®, and the latest in treatments and therapies. Dr. Ma delivered insights on Therapeutic Strategies for Non-Melanoma Skin Cancers, showcasing his expertise and commitment to advancing cancer care. As an Assistant Professor at the University of Wisconsin Carbone Cancer Center, Dr. Ma continues to contribute significantly to the field of oncology. We are proud to have Dr. Ma’s leadership and dedication represented within CAHON.
Liang, Deng, MD, PhD
Elected as the Councilor for Applied Virology of the American Society for Virology (ASV)
During her term as CAHON President from 2024–2026, Dr. Liang Deng has provided dedicated leadership and strong support to the CAHON community. She was recently elected Councilor for Applied Virology of the American Society for Virology (ASV), a leading international organization devoted to advancing virology research and scientific collaboration. In this role, Dr. Deng will help support the advancement of translational virology, viral immunotherapy, antiviral and vaccine development, and therapeutic innovation. We are grateful for Dr. Deng’s leadership within CAHON and are proud to see her continued contributions to the broader scientific and medical communities.
Tong Xiao, PhD
Published Article in the Nature Immunology
As a student of Lifetime CAHON member, Zihai Li, Tong Xiao attends OSUCCC Pelotonia Institute for Immuno-Oncology and recently published an article in the Nature Immunology. The article, "ZFP148 is a transcriptional repressor of cytolytic effector CD8+ T cell differentiation," focuses on, "progenitor CD8+ T cells differentiating into effector and exhausted progenies during chronic antigen stimulation. However, mechanisms that restrain exhaustion and sustain effector differentiation remain incompletely defined." They identify and analyze these occurrences in the article, as well as comparing the results with other infections and diseases, such as cancer.
Read more
Lawrence Wu, MD
2026 ASCO Young Investigator Award Recipient
Dr. Lawrence Wu, an Associate Member of CAHON and 2025 CAHON Young Investigator Award recipient, will be awarded the 2026 ASCO Young Investigator Award. The Conquer Cancer Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. It is an honor to be granted this award (read more). Dr. Wu is grateful to CAHON for the support in his academic endeavors and encouragement throughout his career journey. Congratulations Dr. Wu!
Committee Corner
Academic Committee
Hong Zheng, MD, PhD (Chair)
Wanqing Iris Zhi, MD, PhD (Co-Chair)
Minggui Pan, MD, PhD
Huichun Zhan, MD, MS
Elizabeth Budde, MD, PhD
Jeffrey Pu, MD, PhD
The Academic Committee is excited to launch the 2026 Young Investigator Awards (YIA) with a call for applications for this year's Summer Symposium during ASCO. The application deadline is April 30th. More information can be found here.
In addition to the Summer Symposium, New York Oncology Forum and Winter Symposium, the committee looks forward to accepting applications for the Society of Immunotherapy in Cancer's (SITC) annual meeting for the inaugural Fall Symposium.
Career Development Committee
Hongtao Liu, MD, PhD (Chair)
Mary Li, MD, PhD (Co-Chair)
Jane Liu, MD
Lei Deng, MD
Haoran Li, MD, PhD
Eric Chen, MD, PhD
On March 7th the CAHON Career Development Committee hosted a Career Pathways Webinar to bring together oncologists from academic, community, industry, and policy settings to discuss career paths available within hematology/oncology. Panelists shared insights on key decision points, mentorship, and the trade-offs that shape professional trajectories, along with common pitfalls and lessons learned. The session concluded with an engaging Q&A featuring both pre-submitted and live audience questions.
In case you missed it, the event was recorded for CAHON Members, and can be accessed by logging into your account here.
If you are interested in signing up as a mentee or a mentor, please email info@cahon.org for more information.
Clinical Practice Committee
Shuang Fu, MD, PhD (Chair)
Joyce Huang, MD, PhD (Co-Chair)
Yongli Ji, MD, PhD
Vincent The-Luc Ma, MD
Fengming Zhong, MD, PhD
The Clinical Practice Committee planned another highly successful Community Oncology Forum on February 28th in St. Pete Beach Florida. This CME event brought together experts for engaging panel discussions on breast cancer, lung cancer, lymphoma, hepatocellular carcinoma, AI in oncology, and physician wellness. The sessions delivered cutting-edge insights and practical takeaways for the community. View the meeting report here.
Clinical Research Committee
Tian Zhang, MD, MHS (Chair)
Bo Wang, MD (Co-Chair)
Ronan Hsieh, MD, MS
Jingsong Zhang, MD, PhD
Feng-ming (Spring) Kong, MD, PhD
Xiaolin Zhu, MD, PhD
We’re proud to share that Dr. Bo Wang, Chair of the Clinical Research Committee, has been selected to present research at the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO). Dr. Wang's abstract centers on, "Efficacy, safety, and cytokine profiling with addition of the toll-like receptor (TLR) 7/8 dual agonist EIK1001 to standard of care (SOC) first-line (1L) therapy: The phase 2 TeLuRide-005 trial in stage 4 NSCLC."
This recognition reflects both his leadership in advancing clinical research and the committee’s continued commitment to fostering innovation in oncology. The Clinical Research Committee remains deeply focused on supporting the next generation of investigators and creating opportunities for members to engage in meaningful research.
Event and Education Committee
Yucai Wang, MD, PhD (Chair)
Christine Ye, MD, MS (Co-Chair)
Richard J. Lin, MD, PhD
Charles Jiang, MD, MPH
Gary Lu, MD, PhD
The Event & Education Committee helped organize another a standout Post-ASH Virtual Update on January 28th, offering a CME accredited program that brought our community together to explore the latest breakthroughs from the 2025 ASH Annual Meeting. With expert-led sessions and strong engagement, the event highlighted cutting-edge advances and reinforced CAHON’s commitment to high-quality, impactful education.
For those who missed the Post-ASH Update, the event was recorded for CAHON Members, and can be accessed by logging into your account here.
Fellow Committee
Zhengrui Xiao, MD (Chair)
Chen Zhang, MD (Co-Chair)
Xiao Hu, MD, MPH
Tien-Chan Hsieh, MD
Emily Liang, MD
Xiaocao Xu (Haze), MD
The Fellow Committee hosted another highly successful Applying for Fellowship, webinar on April 11th. The session brought together a dynamic panel of recently matched applicants, faculty, and program directors who shared practical insights and firsthand experiences from the fellowship application process. Attendees benefited from an engaging discussion and interactive Q&A, gaining valuable guidance on preparing competitive applications, navigating interviews, and making informed decisions during the match.
In case you missed it, the event was recorded for CAHON Members, and can be accessed by logging into your account here.
Industry Committee
Jianda Yuan, MD, PhD (Chair)
Ke Liu, MD, PhD (Co-Chair)
Yufeng Li, PhD
Chung-Han Lee, MD, PhD
Zhaohui Jin, MD
Oliver Kong, MD
Jerry Huang, MD, PhD, MBA
The Industry Committee continues to highlight cutting-edge topics at the intersection of innovation and oncology. In December, the committee hosted an AI in Healthcare: Development and Potential Applications webinar, drawing strong engagement from CAHON members and kicking off a new series focused on artificial intelligence in healthcare. Stay tuned for more dynamic programming from the Industry Committee.
The event was recorded for CAHON Members, and can be accessed by logging into your account here.
Membership Committee
Yong Ji, MD, PhD (Chair)
Haixia Qin, MD, PhD (Co-Chair)
Zach Liu, MD
Yiyi Yan, MD, PhD
Deng Zhang, MD, PhD
The Membership Committee is maintaining strong momentum to start the new year. We’re excited to share that 13 new members have joined since the beginning of the year. This steady growth is a testament to both the committee’s dedication and the welcoming spirit of our organization.
Public Relations Committee
Ligeng Tian, MD, PhD (Chair)
Faye Yin, MD, FACP (Co-Chair)
Peter Q Jiang, MD, PhD
Hui Chen, MD, PhD
Yumeng Zhang, MD
The Public Relations Committee did an outstanding job organizing and sharing a comprehensive meeting report from the 2026 Community Oncology Forum (COF)! The report captures key discussions, major takeaways, and critical updates from the meeting, giving members a clear and accessible summary of everything that happened. Thanks to their efforts, members stayed fully informed and gained valuable insights across the network. View the report below.
2026 Meeting Reports:
Community Oncology Forum
CAHON Mentorship Initiative
The CAHON Quarterly Seminar Series promotes education, mentorship, and academic exchange by featuring presentations from a senior faculty member, a junior faculty member, and two fellows in each session. This format fosters cross–career dialogue, highlights innovative research and clinical insights, and supports the professional development of early-career investigators while strengthening collaboration within the oncology community. The next event will take place on May 2nd! - More details and registration can be found here.
If you have an idea for the Quarterly Seminar Series or are interested in joining the mentorship WeChat group and signing up as a mentee or a mentor, please email info@cahon.org for more information.
Recent Events
Post-ASH Virtual Update
CAHON’s Post-ASH Virtual Update on January 28th provided healthcare professionals with a focused review of the most impactful clinical research presented at the recent ASH meeting. As the field of hematology/oncology continues to advance at a rapid pace, new clinical trial findings frequently translate into meaningful changes in clinical practice. This virtual program offered CAHON members and colleagues an opportunity to stay current with emerging data, evolving treatment strategies, and key scientific developments shaping patient care. Continuing Medical Education (CME) credit was available for eligible participants.
The event was recorded for CAHON Members, and can be accessed by logging into your account here.
Quarterly Seminar Series February
The CAHON Quarterly Seminar Series took place on February 7th. This series promotes education, mentorship, and academic exchange through presentations by senior and junior faculty. This session featured presentations by Drs. Chong-xian Pan, Charles Jiang, Qing Li, and Fangyuan Chen, with discussions spanning translational research, health policy, and breast cancer research.
The event was recorded for CAHON Members, and can be accessed by logging into your account here.
Community Oncology Forum
The Community Oncology Forum, held on February 28th in St. Pete Beach, Florida, was another highly successful CME event. The program brought together experts for engaging panel discussions on breast cancer, lung cancer, lymphoma, hepatocellular carcinoma, AI in oncology, and physician wellness.
View Event Photos and Meeting Report
Career Pathways Webinar
The Career Pathways Webinar, held virtually on March 7th, brought together oncologists from academia, community, industry, and policy settings to explore the wide range of career paths within hematology/oncology. Panelists shared insights on key decision points, mentorship, trade-offs, and common pitfalls, followed by an engaging Q&A. Stay tuned for more educational opportunities coming soon.
The event was recorded for CAHON Members, and can be accessed by logging into your account here.
Applying for Fellowship Webinar
On April 11th, CAHON hosted the Applying for Fellowship webinar, drawing more than 40 attendees for an engaging and informative session. A dynamic panel of recently matched applicants, faculty, and program directors shared practical insights and firsthand experiences on building competitive applications, navigating interviews, and making informed decisions during the match, followed by an interactive Q&A.
The event was recorded for CAHON Members, and can be accessed by logging into your account here.
Upcoming Events
-
Summer Symposium & Reception
May 30, 2026
Chicago, IL -
Quarterly Seminar Series
May 2, 2026
via Zoom -
New York Oncology Forum
October 3-4, 2026
Flushing, NY -
Fall Symposium (During the SITC Annual Meeting)
November 6, 2026
Phoenix, AZ -
Winter Symposium & Reception
December 12, 2026
New Orleans, LA
Read more: Upcoming in-person events and Upcoming virtual events
CAHON Awards
Since 2015, CAHON has proudly presented more than 200 prestigious awards.
- Young Investigator Awards: 109+
- Junior Investigator Awards: 30+
- CAHON-CSCO Travel Awards: 20+
- NYOF Young Investigator Travel Awards: 50+
2026 Summer Symposium Young Investigator Awards - Call for Applications!
To foster growth and achievement amongst Chinese American Hematologist and Oncologist Network (CAHON’s) early career or physician-in-training members, CAHON will award up to five Young Investigator Awards (YIA) based on the scientific merit of abstracts submitted to the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.
Read more
CAHON Academic Committee:
Hong Zheng, MD, PhD (Chair)
Wanqing Iris Zhi, MD, PhD (Co-Chair)
Minggui Pan, MD, PhD
Huichun Zhan, MD, MS
Elizabeth Budde, MD, PhD
Jeffrey Pu, MD, PhD
Membership Corner
New CAHON Membership Category - Honorary Lifetime Membership
In February, the inaugural call for nominations was sent out to all CAHON members for CAHON Honorary Lifetime Membership candidates. The selected candidates will be announced and recognized during upcoming CAHON meetings.
2026-2028 Executive Team
There was a record-breaking response to the call for volunteers for the 2026-2028 Executive Team! More than 70 of our members have stepped up to contribute their time and expertise to continue to build on the momentum of the previous term and to advance CAHON’s strategic goals together. Appointments are being finalized, and the new Executive Team will be announced during the upcoming Summer Symposium.
Celebrating Our New Regular Members
CAHON proudly recognizes several of our Associate Members who have now advanced to Regular Member status. This milestone reflects their continued dedication to the field of hematology/oncology and their growing leadership within the profession. We are honored to support these professionals throughout their training and are excited to welcome them as full members of the CAHON community. Their commitment to patient-centered care, professional development, and collaboration strengthens our mission and the future of oncology navigation. Please join us in congratulating these outstanding individuals on this important achievement.
- Jie Chi, MD – Assistant Attending, Memorial Sloan Kettering Cancer Center
- Jiasen He, MD – Assistant Professor, MD Anderson Cancer Center
- Tien-Chan Hsieh, MD – Associate Director, Clinical Medical Science, MediLink Therapeutics
- Jennifer J. Huang, MD, PhD – Assistant Professor, Fred Hutchinson Cancer Center
- Chunjie Li, MD, PhD – Assistant Professor, Washington University School of Medicine
- Emily C. Liang, MD – Assistant Professor in MBT/Immunotherapy, Fred Hutchinson Cancer Center
- Chun T. Siu, DO – Oncologist, Kaiser Permanente Medical Group
- Kevin (Xin) Wang, MD, PhD, FRCP – Medical Oncologist, Princess Margaret Cancer Centre
- Yating Wang, MD – Attending Physician, Ascension All Saints Cancer Center
- Shuo Xu, MD – Clinical Assistant Professor, University of California San Francisco
- Xiaocao (Haze) Xu, MD – Assistant Professor in Thoracic Oncology, University of Massachusetts
- Maggie Y. Zhou, MD – Instructor, Stanford University
Welcoming our New Members Since January 1st!
Associate
- Shuang Gao, MD, MS, MS, MSN, RD – Physician, Kettering Health
- Wenying Liang, MD, PhD – Resident Physician, McLaren Oakland Hospital/Michigan State University
- Mingqian Lin, MD, MS – Resident Physician, Medical College of Wisconsin Affiliated Hospitals
- Xiaoyu Pan, MD, PhD, MPH – Resident Physician, MGB Spaulding Rehabilitation Hospital
- Haoyuan Wang, MD – Resident Physician, The University of Kansas Medical Center
- Jiawei Wei, MD – Physician, St Luke's Hospital
Regular
- Xing Fan, MD, PhD – Staff Clinician, National Institutes of Health
- Dan Feng, MD, PhD – Assistant Professor, Icahn School of Medicine at Mount Sinai
- Ning Jin, MD – Physician/Associate Professor, The Ohio State University
- Mingjia Li, MD – Physician/Assistant Professor, The Ohio State University
- Xin Yao, MD – Physician, Cleveland Clinic Florida
- Ling Zhang, MD – Professor/Senior Member, H Lee Moffitt Cancer Center
Allied
- Rose Wang, MBA – Founder & CEO, 1104Health
Membership Categories:
Associate Member: Dues Waived, including the first year after completing medical training, when upgrading to regular membership
Regular Member: $100.00 (USD) annually
Allied Member: $100.00 (USD) annually
Lifetime membership status will be conferred to Regular or Allied members if they have maintained their membership for at least eight years!
For more information on membership categories and to apply for membership, visit here.
The Journal of Hematology & Oncology (JHO) - Official Journal of CAHON
The Journal of Hematology & Oncology provides a forum for top-quality research and is the leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists.
Prof Delong Liu, Editor-in-Chief
Journal of Hematology & Oncology
Impact factor 40.4!
Link to articles: https://jhoonline.biomedcentral.com/articles
CAHON Social Media
In October 2024, CAHON officially launched its X and LinkedIn accounts. Follow us for member highlights, updates, and more.
We also have an exclusive Members-Only WeChat group. To join, please send the following details to info@cahon.org.
- Your WeChat ID (adjusted to reflect your professional name, affiliation or location, and specialty)
- A short introduction that includes your current role/position, and ALL prior education and work experience
- Professional Photo
- Chinese name (if applicable)
Please review our social media policy: Social Media Policy
We Need Your Support - Consider a Donation to CAHON
Easy Ways to Support:
-
Visit https://www.cahon.org to make a tax-deductible donation
-
Request a Corporate Match - Many companies will match a donation if you provide them with CAHON tax ID number
-
Include CAHON in your Donor-Advised Fund providing CAHON tax ID number
Thank You to Our 2026 Corporate Partners!
Partnering for Progress: How Our Corporate Partners Are Powering Cancer Innovation
|
|
Agios is a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts. The company’s vision is to redefine the future of rare disease treatment. Fueled by connections, it builds trusted partnerships with communities – collaborating to develop and deliver innovative medicines that have the potential to transform lives. With a foundation in hematology, Agios combines biological expertise with real-world insights to advance a growing pipeline of rare disease medicines that reflect the priorities of the people it serves. To learn more, visit www.agios.com and follow Agios on LinkedIn and X. |
|
|
BeOne Medicines is a global oncology company discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of novel therapeutics through its internal capabilities and collaborations. Our global team works across six continents, driven by scientific excellence and speed to reach more patients than ever. Learn more at https://beonemedicines.com/ |
|
|
Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by drug discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules and biotherapeutics. or information about the company and its mission to help cancer patients recover stronger and live longer, visit www.exelixis.com, follow @ExelixisInc on X (Twitter), like Exelixis, Inc. on Facebook and follow Exelixis on LinkedIn. |
|
|
Ipsen is a global biopharmaceutical company focused on innovation and specialty care. At Ipsen, we develop and commercialize medicines in three key therapeutic areas – Oncology, Neuroscience and Rare Disease. Our focus in oncology is on some of the most difficult-to-treat cancers. We have a portfolio of therapies for solid tumors and in hematology aimed at improving the lives of people living with pancreatic cancer, gastrointestinal and pancreatic neuroendocrine tumors, and carcinoid syndrome. Every day, our more than 5,000 employees worldwide, including nearly 800 in North America, work diligently to improve lives around the world. For more information, please visit www.ipsen.com/us. |
|
|
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram and LinkedIn. |
|
|
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. To learn more, visit https://www.natera.com/oncology/ |
|
|
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Learn more about our commercialized and investigational products at https://www.rigel.com/pipeline |
Thank You to Our 2026 Annual Oncology Supporters!
